Diabetes, Vol 38, Issue 2 198-204, Copyright © 1989 by American Diabetes Association
Relative importance of extracellular and intracellular Ca2+ for acetylcholine stimulation of insulin release in mouse islets
MP Hermans and JC Henquin
Unit of Diabetology and Nutrition, University of Louvain School of Medicine, Brussels, Belgium.
Mouse islets were used to study whether mobilization of intracellular Ca2+
is sufficient to account for acetylcholine (ACh) amplification of
glucose-induced insulin release. In the presence of 15 mM glucose, the
acceleration of 45Ca efflux and insulin release by 1-100 microM ACh
increased with the concentration of extracellular Ca2+ (0.25-2.5 mM). Low
concentrations of the Ca2+-channel blockers D 600 (1 microM) or nifedipine
(0.1 microM) partially inhibited glucose-induced insulin release and its
amplification by ACh. At higher concentrations, D 600 (25 microM) or
nifedipine (2 microM) practically abolished the ionic and secretory effects
of 1 microM ACh. However, 100 microM ACh still caused a fast, large, but
transient acceleration of 45Ca efflux, accompanied by a small, short-lived
release of insulin. Similar results were obtained in a Ca2+-free medium,
indicating that this peak of 45Ca efflux reflects Ca2+ mobilization.
Addition of nifedipine or omission of Ca2+ during ACh stimulation rapidly
and strongly inhibited 45Ca efflux and insulin release. Both glucose and
ACh-induced 45Ca uptake were inhibited by D 600. Only high concentrations
of ACh (100 microM) mobilize enough cellular Ca2+ to trigger a small and
transient insulin release when Ca2+ influx is prevented or impossible. A
continuous influx of Ca2+ is necessary for low ACh concentrations to
increase release and for high concentrations to have a sustained effect.
The amplification of release by the neurotransmitter results from a slight
enhancement of Ca2+ influx associated with a marked increase in the
effectiveness of incoming Ca2+ on the releasing machinery.